News & Events
Get updatesUpcoming Events
Join us Friday, March 8th, from 3-4pm ET for the CRISPR for Cure webinar presented by Dr. Liang Shan!
Recent News
The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression
Read more
New CRISPR-Based HIV Therapy Could Eliminate Need for Antiretrovirals
Read more
First individual treated with CRISPR-based HIV therapy, a breakthrough treatment pioneered by researchers at Lewis Katz School of Medicine at Temple University and developed by Excision BioTherapeutics
Read more
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Read more
Longtime HIV Patient is Effectively Cured After Stem Cell Transplant
Read more
Temple’s HIV Treatment Undergoes Clinical Trial
Read more
First Clinical Trial CRISPR-Based HIV Therapy Founded on Breakthrough Research at LKSOM
Read more
The Third Era of the Martin Delaney Collaboratories
Read more
A Potential One-Dose Treatment to “Functionally Cure” HIV Will be Tested in Human Trials
Read more
Temple Researchers Awarded Prestigious Grant from the NIH’s Martin Delaney Collaboratories for HIV Cure Research Program
Read more